Ingredient record · Nerve pain and seizure medicine
Gabapentin: bans, restrictions and failed batches in India
Last checked 20 September 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Jul 2026
2 entries containing Gabapentin are on India's banned-drugs list, and 1 is banned today. 18 batches of medicines containing Gabapentin failed a government lab test between August 2019 and May 2026, from 13 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.
1
Banned combinations in force
1
Other listed orders (stayed, restricted, quashed)
18
Batches failed a lab test
May 2026
Latest lab alert
On the banned-drugs list
Gabapentin on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.
| Drug / combination | Action | Notification | Date | Order | Status note |
|---|---|---|---|---|---|
| Gabapentin + Mecobalamin + Pyridoxine + ThiamineFixed-dose combination · vitamins | Banned | S.O. 4463(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Gabapentin + Mecobalamin + Pyridoxine + ThiamineFixed-dose combination · vitamins | Quashed | S.O. 798(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
Products that failed lab tests
Product names as printed by the testing labs, grouped. Open a product to see every batch number.
| Product | Batches | Makers | Latest |
|---|---|---|---|
| Gabapentin | 11 | 8 | May 2026 |
| Gabapentin Nortriptyline Hydrochloride | 1 | 1 | May 2025 |
| Lidocaine Hydrochloride Gabapentin | 1 | 1 | Apr 2025 |
| Progaba | 1 | 1 | Apr 2025 |
| Gabapentin Amitriptyline Hcl | 1 | 1 | Nov 2023 |
| Gabon | 1 | 1 | Mar 2023 |
| Gebcare | 1 | 1 | Feb 2023 |
| Gabapentin Nortriptyline | 1 | 1 | Aug 2019 |
Most recent failed batches
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Gabapentin Tablets IP 300 mg | TSF-DO897Mfg 2025-05 · Exp 2027-04 | Spen Formulations Pvt. Ltd | The sample does not conform to IP 2022 requirements w.r.t Dissolution TestDissolution | DTL,Dalgate Srinagar kashmirState lab | May 2026 |
| Gabapentin capsules IP 400mg | LPC25029Mfg 2025-02 · Exp 2027-01 | Levotic Pharma | Description and Uniformity of WeightDescription | SDTL, PunjabState lab | Feb 2026 |
| Gabapentin Capsules IP 300mg. (Pebammyl-3G) | AFC2411056Mfg 2024-11 · Exp 2026-10 | Alifecare FormulationHimachal Pradesh | The sample does not conform to claim as per I.P. 2022 even at Stage-III as the average release is 65.02% of labelled claim against Q value of NLT 80% of labelled claim.Labelling | State Drugs Laboratory, PunjabState lab | Jul 2025 |
| Gabapentin Capsules IP 300mg. (Pebammyl-3G) | AFC2501028Mfg 2025-01 · Exp 2026-12 | Alifecare FormulationHimachal Pradesh | The sample does not conform to claim as per I.P. 2022 even at Stage-III as the average release is 68.50% of labelled claim against Q value of NLT 80% of labelled claim.Labelling | State Drugs Laboratory, PunjabState lab | Jul 2025 |
| Gabapentin Capsules IP 300mg. (Pebammyl-3G) | AFC2501029Mfg 2025-01 · Exp 2026-12 | Alifecare FormulationHimachal Pradesh | The sample does not conform to claim as per I.P. 2022 even at Stage-III as the average release is 68.88% of labelled claim against Q value of NLT 80% of labelled claim.Labelling | State Drugs Laboratory, PunjabState lab | Jul 2025 |
| Gabapentin Capsules IP 300mg. (Pebammyl-3G) | AFC2502059Mfg 2025-02 · Exp 2027-01 | Alifecare FormulationHimachal Pradesh | The sample does not conform to claim as per I.P. 2022 even at Stage-III as the average release is 71.22% of labelled claim against Q value of NLT 80% of labelled claim.Labelling | State Drugs Laboratory, PunjabState lab | Jul 2025 |
| Gabapentin Capsules IP 300mg. (GABATEC-300) | SG2412559Mfg 2024-12 · Exp 2026-11 | Scout Lifescience Pvt. LtdHaryana | Uniformity of WeightUniformity of weight/content | State Drugs Laboratory, PunjabState lab | May 2025 |
| Gabapentin & Nortriptyline Hydrochloride Tablets (GABVONT400) | HT24642Mfg 2024-12 · Exp 2026-11 | HBC Healthcare Pvt. LtdGujarat | The sample does not confirm to the claim with respect to Assay of NortriptylineAssay | DTL,Jaipur (State Lab)State lab | May 2025 |
| Progaba Gel (Lidocaine Hydrochloride & Gabapentin Gel) | PSWAB66Mfg 2024-06 · Exp 2025-11 | Pure & Cure Healthcare Pvt. LtdUttarakhand | Sample does not conform to Label claim with respect to the content of GabapentinLabelling | DTL MaduraiState lab | Apr 2025 |
| Lidocaine Hydrochloride and Gabapentin Gel (Gabaneuron Gel) | PWBBO7Mfg 2024-06 · Exp 2025-11 | Pure & Cure Healthcare Pvt. LtdUttarakhand | Sample does not conform to lebel claim with respect to the content of GabapentinOther | DTL MaduraiState lab | Apr 2025 |
| Gabapentin Tablets IP (Gabon-300) | MT225040Mfg 2022-11 · Exp 2024-10 | Mascot Health Series Pvt. LtdUttarakhand | Related SubstancesRelated substances | CDL KolkataCDSCO lab | Apr 2024 |
| Gabapentin & Amitriptyline HCl Tablets (GABAMER AT) | T-230420Mfg 2023-04 · Exp 2025-03 | Vilin Bio Med LtdUttarakhand | Assay of Amitriptyline HydrochlorideAssay | CDL KolkataCDSCO lab | Nov 2023 |
| Gabon-300 Tablets (Gabapentin Tablets I.P.) | MT225040Mfg 2022-11 · Exp 2024-10 | Mascot Health Series Pvt. LtdUttarakhand | Related SubstancesRelated substances | CDTL KolkataCDSCO lab | Mar 2023 |
| Gabapentin Tablets I.P. | 22S1GTB467Mfg 2022-11 · Exp 2024-10 | Synokem Pharmaceuticals LtdUttarakhand | Related SubstancesRelated substances | CDTL KolkataCDSCO lab | Mar 2023 |
| Gebcare - 100 (Gabapentin Tablets I.P. 100 mg) | T221337Mfg 2022-05 · Exp 2024-04 | United Bioceuticals Pvt. LtdUttarakhand | Related SubstancesRelated substances | CDL KolkataCDSCO lab | Feb 2023 |
Showing 15 of 18 records
Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.